Clinical Trials Logo

Clinical Trial Summary

The overall objective of this pilot study is to collect immunological and safety data following administration of vaccinations with HLA-A2. This data will be used to decide whether a larger study of clinical efficacy is warranted.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Glioma
  • Newly Diagnosed Pediatric High Grade Glioma
  • Newly Diagnosed Pediatric Pontine Glioma
  • Recurrence
  • Recurrent Pediatric High Grade Glioma
  • Recurrent Pediatric Low Grade Glioma

NCT number NCT01130077
Study type Interventional
Source University of Pittsburgh
Contact
Status Active, not recruiting
Phase Phase 1
Start date February 2009
Completion date December 31, 2025